NO173097C - 10-propynyl-norandrostener, og antikonsepsjonsmiddel inneholdende disse - Google Patents

10-propynyl-norandrostener, og antikonsepsjonsmiddel inneholdende disse

Info

Publication number
NO173097C
NO173097C NO894276A NO894276A NO173097C NO 173097 C NO173097 C NO 173097C NO 894276 A NO894276 A NO 894276A NO 894276 A NO894276 A NO 894276A NO 173097 C NO173097 C NO 173097C
Authority
NO
Norway
Prior art keywords
compounds
norandrostenes
anticonctions
propynyl
estrogens
Prior art date
Application number
NO894276A
Other languages
English (en)
Norwegian (no)
Other versions
NO894276D0 (no
NO894276L (no
NO173097B (no
Inventor
John O'neal Johnston
Gene Warwick Holbert
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NO894276D0 publication Critical patent/NO894276D0/no
Publication of NO894276L publication Critical patent/NO894276L/no
Priority to NO902430A priority Critical patent/NO173098C/no
Publication of NO173097B publication Critical patent/NO173097B/no
Publication of NO173097C publication Critical patent/NO173097C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0011—Androstane derivatives substituted in position 17 by a keto group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0025—Esters

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Silicon Polymers (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO894276A 1988-10-27 1989-10-26 10-propynyl-norandrostener, og antikonsepsjonsmiddel inneholdende disse NO173097C (no)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO902430A NO173098C (no) 1988-10-27 1990-05-31 Analogifremgangsmaate for fremstilling av terapeutisk aktive 10-propynol-androstener

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/263,091 US4882322A (en) 1988-10-27 1988-10-27 3β,17β-hydroxy-substituted steroids and related steroidal compounds

Publications (4)

Publication Number Publication Date
NO894276D0 NO894276D0 (no) 1989-10-26
NO894276L NO894276L (no) 1990-04-30
NO173097B NO173097B (no) 1993-07-19
NO173097C true NO173097C (no) 1993-10-27

Family

ID=23000340

Family Applications (1)

Application Number Title Priority Date Filing Date
NO894276A NO173097C (no) 1988-10-27 1989-10-26 10-propynyl-norandrostener, og antikonsepsjonsmiddel inneholdende disse

Country Status (18)

Country Link
US (1) US4882322A (fr)
EP (1) EP0366144B1 (fr)
JP (1) JP2750621B2 (fr)
KR (1) KR900006360A (fr)
CN (1) CN1042363A (fr)
AT (1) ATE111478T1 (fr)
AU (1) AU619608B2 (fr)
CA (1) CA2001264C (fr)
DE (1) DE68918219T2 (fr)
DK (1) DK533189A (fr)
ES (1) ES2063801T3 (fr)
FI (1) FI895084A7 (fr)
HU (1) HU204065B (fr)
IL (1) IL92103A0 (fr)
NO (1) NO173097C (fr)
NZ (1) NZ231107A (fr)
PT (1) PT92113B (fr)
ZA (1) ZA898025B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5166201A (en) * 1990-11-30 1992-11-24 Merrell Dow Pharmaceuticals Inc. 2β,19-ethylene bridged steroids as aromatase inhibitors
AU4093799A (en) 1998-05-22 1999-12-13 Board Of Trustees Of The Leland Stanford Junior University Bifunctional molecules and therapies based thereon
WO2005097141A2 (fr) * 2003-11-24 2005-10-20 Merck & Co., Inc. Modulateurs des recepteurs d'oestrogenes
WO2005051972A1 (fr) * 2003-11-24 2005-06-09 Merck & Co., Inc. Modulateurs des recepteurs estrogeniques
CA2789262C (fr) 2005-04-28 2016-10-04 Proteus Digital Health, Inc. Systeme pharma-informatique
EP1945240B1 (fr) 2005-09-16 2016-12-28 Raptor Pharmaceutical Inc Compositions de proteines rap specifiques des proteines contenant du cr, et leurs utilisations
TR201908314T4 (tr) 2009-02-20 2019-06-21 2 Bbb Medicines B V Glutatyon bazlı ilaç dağıtım sistemi.
KR101909711B1 (ko) 2009-05-06 2018-12-19 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법
CN103555806B (zh) * 2013-11-16 2015-05-13 江南大学 一种高效利用亚麻刺盘孢霉合成7α-羟基-雄甾烯酮的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4322416A (en) * 1980-06-27 1982-03-30 Merrell Dow Pharmaceuticals Inc. 10-Alkynyl steroids
GB8531747D0 (en) * 1985-12-24 1986-02-05 Erba Farmitalia 10beta-alkynylestrene derivatives

Also Published As

Publication number Publication date
DE68918219D1 (de) 1994-10-20
ES2063801T3 (es) 1995-01-16
PT92113B (pt) 1995-06-30
HU204065B (en) 1991-11-28
AU619608B2 (en) 1992-01-30
NO894276D0 (no) 1989-10-26
JPH02174793A (ja) 1990-07-06
FI895084A7 (fi) 1990-04-28
JP2750621B2 (ja) 1998-05-13
HUT52113A (en) 1990-06-28
DK533189D0 (da) 1989-10-26
KR900006360A (ko) 1990-05-08
PT92113A (pt) 1990-04-30
NO894276L (no) 1990-04-30
ATE111478T1 (de) 1994-09-15
US4882322A (en) 1989-11-21
EP0366144A1 (fr) 1990-05-02
CN1042363A (zh) 1990-05-23
ZA898025B (en) 1990-07-25
HU895457D0 (en) 1990-01-28
FI895084A0 (fi) 1989-10-26
IL92103A0 (en) 1990-07-12
DE68918219T2 (de) 1995-02-02
EP0366144B1 (fr) 1994-09-14
AU4367989A (en) 1990-05-31
NO173097B (no) 1993-07-19
NZ231107A (en) 1992-03-26
CA2001264C (fr) 2001-05-01
CA2001264A1 (fr) 1990-04-27
DK533189A (da) 1990-04-28

Similar Documents

Publication Publication Date Title
BG101966A (en) Application of 1l-agonist for the treatment of lack of urine retention
PT86652A (pt) Steroid 5-alpha-reductase inhibitors
SI1169337T1 (en) Steroid nitrates for the treatment of oxidative injury and endothelial dysfunction
NO173097C (no) 10-propynyl-norandrostener, og antikonsepsjonsmiddel inneholdende disse
IT8249275A0 (it) Composti naftochinonici utili come agenti antimalarici e anticoccidici e procedimento per la loro preparazione
ZA948310B (en) Delta16unsaturated c17 heterocyclic steroids useful as steroid c17-20lyase inhibitors
JPS5738798A (en) 10-(1,2-propadienyl)steroid as non-reversible aromatase inhibitor
GR82160B (fr)
ZA899670B (en) Phosphonic acid substituted steroids as steroid 5-alpha-reductase inhibitors
IN167848B (fr)
ES2171943T3 (es) Nuevo procedimiento de isomerizacion del radical metilo en posicion 10 de derivados de eritromicina.
GB2188932B (en) Steroidal compounds and process for lengthening the side-chain of certain steroids
BG102716A (en) Method for the treatment of cardiac insufficiency by means of formulations opposing the endotheline
GR850139B (fr)
KR900009591A (ko) 피리딘-3-퍼옥시카르복실산 모노퍼술페이트
ZA851927B (en) Pharmaceutical composition containing 9alpha,11beta-dichloro-16alpha-methyl-21-oxycarbonyldicyclohexylmethyloxy preggna-1,4-diene-3,20-dione
ATE124952T1 (de) Haloethyl substituierte enzymhemmende steroiden.
DE3160507D1 (en) Process for the preparation of 3,20-dioxo-pregn-4-ene and/or 3,20-dioxo-pregna-1,4-diene
ATE18039T1 (de) 2,3,5,6-tetrasubstituierte p-benzochinone, ihre herstellung und verwendung.
DK0742784T3 (da) Fremgangsmåde til konditionering af slam
IT1130297B (it) Procedimento per il trattamento di acque di scarico solforate mediante perossido di idrogeno
BA97185B1 (bs) Postupak za dobijanje supstituisanih androsta-1,4-dien-3,17-diona
DE3765250D1 (de) Verwendung von 24,25-dihydroxycholecalciferol zur behandlung von harnsteinen.